Coagulopathy associated with vitamin E ingestion.
D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D002994:Clofibrate / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D011517:Prothrombin Time; D011655:Pulmonary Embolism / Q000188:drug therapy; D012964:Sodium / Q000627:therapeutic use; D014810:Vitamin E / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014812:Vitamin K / Q000097:blood; D014813:Vitamin K Deficiency / Q000150:complications; D014859:Warfarin / Q000627:therapeutic use
D001779:Blood Coagulation Factors; D014812:Vitamin K; D014810:Vitamin E; D014859:Warfarin; D012964:Sodium; D002994:Clofibrate